Home
This site is intended for healthcare professionals

Growth Hormone Deficiency 2025: Diagnosis, Management & Evolving Therapies

3rd Apr 2025
11:30pm - 1:00am (GMT)
3rd - 4th Apr 2025
11:30pm - 1:00am (GMT)
Hosted on MedAll
Attendance certificate available
This event has ended. Similar events
Free
ONLINE

Description

This program is supported by an independent education grant from Novo Nordisk. This online education program has been designed solely for healthcare professionals in the USA. The content is not available for healthcare professionals in any other country.

Accreditation: 1.5 AMA PRA Category 1 Credits™ are available for this education

Join leading GHD expert Prof. Sasigarn Bowden of Nationwide Children's Hospital for this live online teaching session as she provides an in-depth approach to evaluating and managing patients with growth hormone deficiency (GHD). This interactive case based session covers strategies for integrating clinical presentation, and genetic testing to differentiate GHD from other conditions with similar symptoms. Learn how to utilize appropriate diagnostic tests, collaborate with specialists for accurate diagnosis, and identify suitable candidates for transitioning from daily GH therapy to long-acting GH (LAGH) based on clinical criteria and patient needs. The session will include an interactive Q&A with Dr. Bowden.

Key Topics Covered:

  • Evaluating patients with suspected GHD using clinical, laboratory, and genetic testing
  • Differentiating GHD from other conditions to ensure accurate and timely diagnosis in pediatric patients
  • Interpreting diagnostic test results in the context of individual patient profiles
  • Collaborating with specialists to confirm diagnosis and streamline referrals for comprehensive care
  • Selecting appropriate candidates for transitioning from daily GH therapy to LAGH based on clinical criteria and patient needs

How to Claim Credit

  1. Complete the Post-Test/Evaluation at the end of the event (we'll email it to participants and put it in the chat)
  2. A link to your certificate & credit will be emailed to you

Professor Sasigarn Bowden

Sasigarn Bowden, MD, is a pediatric endocrinologist at Nationwide Children's Hospital and a clinical professor of pediatrics at The Ohio State University College of Medicine. She earned her medical degree from Chiang Mai University in Thailand, followed by pediatric training at Prince of Songkla University and the University of Tennessee. Dr. Bowden completed a fellowship in pediatric endocrinology at Cincinnati Children’s Hospital. Board-certified in pediatrics and pediatric endocrinology, her clinical and research focus includes metabolic bone disorders, pediatric osteoporosis, growth, and diabetes. In addition to her clinical and research work, Dr. Bowden is actively involved in medical education, mentoring and teaching medical students, residents, and fellows. She contributes to educational and clinical initiatives at Nationwide Children's Hospital, helping to train the next generation of pediatric endocrinologists through hands-on teaching, lectures, and curriculum development.

Who Should Watch:

  • Endocrinologists
  • Pediatric Endocrinologists
  • Primary Care Physicians
  • Pediatricians
  • Internal Medicine Physicians
  • Nurse Practitioners
  • Physician Assistants
  • Pharmacists
  • Pediatric Nurse Specialists

Continuing Education Information

This continuing education activity will be provided by AffinityCE and MedAll. This activity will provide continuing education credit for physicians. A statement of participation is available to other attendees.

Faculty

Prof. Sasigarn Bowden

Disclosures

Sasigarn Bowden’s institution has received research funding from Ultragenyx, Lumos Pharma and Biomarin. She has no unapproved product related discussions to disclose.

AffinityCE staff, MedAll staff, as well as planners and reviewers, have no relevant financial relationships with ineligible companies to disclose.

Mitigation of Relevant Financial Relationships

AffinityCE adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible companies. Relevant financial relationships were mitigated by the peer review of content by non-conflicted reviewers prior to the commencement of the program.

Activity Accreditation for Health Professions

Physicians

This activity will be planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and Medall. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™.

Physician Assistants

This activity will be planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physician assistants should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners

This activity will be planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.

Nurses & Other Professionals

All other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.

Participation Costs

There is no cost to participate in this program.

Learning objectives

  1. Evaluate patients with suspected GHD by integrating clinical presentation, laboratory findings, and genetic testing:
  2. Differentiate GHD from other conditions with similar symptoms to ensure accurate and timely diagnosis in both pediatric and adult patients.
  3. Utilize appropriate diagnostic tests and interpret the results in the context of each patient’s clinical profile. Collaborate with specialists, when needed, to confirm the diagnosis and streamline the referral process for comprehensive care.
View all

Similar events and on demand videos

 
3rd - 4th Apr 2025
11:30pm - 1:00am (GMT)
Hosted on MedAll
Attendance certificate available
This event has ended. Similar events
Free
ONLINE